Cite

HARVARD Citation

    Salles, G. et al. (n.d.). ESTIMATION OF LONG‐TERM SURVIVAL WITH TAFASITAMAB + LENALIDOMIDE (LEN) IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL). Hematological oncology. p. n/a. [Online]. 
  
Back to record